EconPapers    
Economics at your fingertips  
 

Biotechnology: Genomics and us

Michael Rawlins ()
Additional contact information
Michael Rawlins: Michael Rawlins is president of the Royal Society of Medicine, London. The author was chairman of the National Institute for Health and Care Excellence from 1999 to 2013.

Nature, 2013, vol. 498, issue 7452, 34-34

Abstract: Michael Rawlins examines a call for biotechnology to be geared towards public health.

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/498034a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:498:y:2013:i:7452:d:10.1038_498034a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/498034a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:498:y:2013:i:7452:d:10.1038_498034a